Spotlight on cancer
Join the hunt for biomarkers
Daniel Hayes has watched the identification of biological markers of disease go from a “sleepy niche” to an increasingly important aspect of personalized care. “When I started, there was little funding for tumour biomarkers in any way, shape or form in the clinic, and there was little if any academic credit given for doing so,” says the cancer researcher at the University of Michigan in Ann Arbor.
Paul Smaglik
Appendices
Related links
Related links in Nature Research
Related links
Related external links
Liquid biopsy in 2016: Circulating tumour cells and cell-free DNA in gastrointestinal cancer
Cancer biomarkers: Written in blood
Rights and permissions
About this article
Cite this article
Spotlight on Cancer. Nature (2017). https://doi.org/10.1038/nj0506
Published:
DOI: https://doi.org/10.1038/nj0506